Antibiotic-Polyphosphate Nanocomplexes: A Promising System for Effective Biofilm Eradication
Dennis To,Mariana Blanco Massani,Débora Coraça-Huber,Anna Seybold,Fabrizio Ricci,Katrin Zöller,Andreas Bernkop-Schnürch
DOI: https://doi.org/10.2147/ijn.s473241
IF: 7.033
2024-09-19
International Journal of Nanomedicine
Abstract:Dennis To, 1 Mariana Blanco Massani, 1 Débora C Coraça-Huber, 2 Anna Seybold, 3 Fabrizio Ricci, 1, 4 Katrin Zöller, 1 Andreas Bernkop-Schnürch 1 1 Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria; 2 Research Laboratory for Implant Associated Infections (BIOFILM LAB), Experimental Orthopaedics, University Hospital for Orthopaedics and Traumatology, Medical University Innsbruck, Innsbruck, Austria; 3 Department of Zoology, University of Innsbruck, Innsbruck, Austria; 4 Thiomatrix Forschungs- und Beratungs GmbH, Innsbruck, Austria Correspondence: Andreas Bernkop-Schnürch, Email Purpose: The eradication of bacterial biofilms poses an enormous challenge owing to the inherently low antibiotic susceptibility of the resident microbiota. The complexation of antibiotics with polyphosphate can substantially improve antimicrobial performance. Methods: Nanoparticular complexes of the model drug colistin and polyphosphate (CP-NPs) were developed and characterized in terms of their particle size and morphology, polydispersity index (PDI), zeta potential, and cytotoxicity. Enzyme-triggered monophosphate and colistin release from the CP-NPs was evaluated in the presence of alkaline phosphatase (AP). Subsequently, antimicrobial efficacy was assessed by inhibition experiments on planktonic cultures, as well as time-kill assays on biofilms formed by the model organism Micrococcus luteus . Results: The CP-NPs exhibited a spherical morphology with particle sizes < 200 nm, PDI < 0.25, and negative zeta potential. They showed reduced cytotoxicity toward two human cell lines and significantly decreased hemotoxicity compared with native colistin. Release experiments with AP verified the enzymatic cleavage of polyphosphate and subsequent release of monophosphate and colistin from CP-NPs. Although CP-NPs were ineffective against planktonic M. luteus cultures, they showed major activity against bacterial biofilms, outperforming native colistin treatment. Strongly elevated AP levels in the biofilm state were identified as a potential key factor for the observed findings. Conclusion: Accordingly, polyphosphate-based nanocomplexes represent a promising tool to tackle bacterial biofilm. Keywords: polyphosphate, colistin, antimicrobial, nanoparticle, nanocomplex Graphical Biofilms are complex multicellular microbial living communities that represent one of the most widespread and predominant living patterns in existence. 1 A vast number of microorganisms can attach to a surface and grow as biofilm, forming three-dimensional structures at various interfaces. The residing microbiota grows at a high cell density and excretes a matrix of extracellular polymeric substances (EPS) surrounding and protecting microorganisms living in the biofilm. Biofilm colonies are typically characterized by tremendously reduced antibiotic susceptibility. 2 Although an antibiotic agent can be highly effective against planktonic microbes, it can be rendered useless once it encounters a biofilm infection. Moreover, biofilms can simultaneously host multiple microbial species. According to the National Institute of Health 65% of all microbial illnesses and 80% of chronic infections are associated with biofilm formation. 3 Biofilm formation occurs similarly on medical devices, such as catheters, heart valves or prostheses as well as on various body surfaces, eg mucosal membranes of the digestive and respiratory tract. 4 Nonetheless, there is no current consensus on the mechanism of biofilm resistance as biofilms still remain poorly understood. Multiple factors appear to be involved, including alterations in metabolism and growth rate, the activation of species-specific resistance genes and an insufficient penetration of the antibiotic inside the biofilm due to protection by the biofilm-matrix. 5,6 Owing to the multifactorial nature of biofilm tolerance to antibiotics, the treatment of biofilm-associated infections is very challenging, and the use of combination therapies is often required. Among the antibiotic agents used, particularly those exhibiting cationic charges, such as the peptide colistin, are prone to losing antimicrobial efficacy in the presence of biofilms. Electrostatic interactions with negatively charged components of the biofilm matrix, such as extracellular DNA (eDNA) or polysaccharides, can hinder or at least delay the penetration of the antibiotic, and might be a key reason for minor efficiency. 4,7–9 Identifying and consequently targeting unique bio -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology